Scientific Programme DZHK Retreat
Preliminary programme (last updated: 2 September 2024):
Thursday, 12 September 2024
13:30 - 14:30 | Registration and welcome coffee
Opening
Chair: Holger Gerhardt
14:30-15:00 | Welcome and state of affairs, Stefanie Dimmeler, Steffen Massberg, Holger Gerhardt, Katharina Eulenburg
15:00-15:30 | 1st Keynote: New mechanisms of hypertension and target organ damage - basic and translational journey, Tomasz Guzik (Edinburgh, UK)
1st Session: New approaches in cardiovascular research
Chairs: Laura Zelarayan & Dominik Müller
15:30-15:45 | New pathways for drug delivery: Inhaled peptide-loaded nanoparticles, Alessio Alogna (Berlin)
15:45-16:00 | Linking chromatin structure to disease variants and gene programs in human cardiomyocytes, Shaza Haydar (Heidelberg)
16:00-16:15 | Mechanical unloading reveals a latent regeneration potential in the human heart, Olaf Bergmann (Göttingen)
16:15-16:30 | Sleep disturbance and cardiac disease, Karin Ziegler (München)
16:30-16:45 | Imaging, molecular signals and phenotypes – multidimensional AI based models to personalize prevention, Stefan Blankenberg (Hamburg)
16:45-17:00 | Group photo
17:00-17:30 | Coffee break
Highlights from the Young DZHK Retreat
Chairs: Sonia Singh, Simone-Franziska Glaser, Michael Molitor
17:30-18:15 | Speakers and talks will be determined in Frankfurt a.M.
Best presentations of each session were voted for by the Young DZHK Retreat participants. Winners are awarded with prizes sponsored by a private donation.
19:00 | Dinner buffet on board & get together, doors open 18:30
Friday, 13 September 2024
2nd Session: Heart failure - highlights from the partner sites
Chairs: Elisabeth Zeisberg & Norbert Frey
8:30-8:45 | Single cell analysis for personalized medicine, Henrike Maatz (Berlin)
8:45-9:00 | RBM20 mislocalization in dilated cardiomyopathy, Julia Kornienko (Heidelberg)
9:00-9:15 | Targeting endogenous membrane repair mechanisms in cardiac disease, Sören Brandenburg (Göttingen)
9:15-9:30 | Decipher HFpEF-DZHK12: Validation of cardiovascular magnetic resonance against invasive haemodynamics in patients with heart failure with preserved ejection fraction, Eike Nagel (Frankfurt)
9:30 - 10:00 | 2nd Keynote: TAVR and neuro protection - What have we learnt? Alexandra Lansky (Yale School of Medicine, New Haven/USA)
10:00-11:00 | Coffee break & checking out of rooms
3rd Session: From bench to industry
Chair: Thomas Eschenhagen
11:00-11:10 | EHTs as an advanced in vitro model for drug testing - DINABIOS, Thomas Eschenhagen (Hamburg)
11:10-11:20 | MYBPC3 gene therapy and spinout - DINAQOR, Lucie Carrier (Hamburg)
11:20-11:30 | Targeting RNA viruses with disruptive tech - Avocet Biosciences, Elisabeth Zeisberg (Göttingen)
11:30-11:40 | Therapeutic target and drug discovery - Genome Biologics, Jaya Krishnan (Frankfurt)
11:40-11:50 | Innovative therapies for cardiovascular disease - REVIER Therapeutics, Johannes Backs (Heidelberg)
11:50-12:00 | Targeted RNA therapy for organs - RNATICS, Stefan Engelhardt (München)
12:00-12:45 | Panel discussion
12:45-13:45 pm | Lunch break
4th Session: Vascular disease - highlights from the partner sites
Chairs: Dorothee Atzler & Philipp Wild
13:45-14:00 pm | Cardiovascular protection due to non- and coding genes at the CDH13 locus, Zhifen Chen (Munich)
14:00-14:15 pm | Metabolic regulation of vascular aging, Sofia Iris Bibli (Mannheim)
14:15-14:30 pm | Neuro-vascular interaction in cardiac aging, Julian U. G. Wagner (Frankfurt)
14:30-14:45 pm | DEDICATE-DZHK6 Trial: Randomized trial of TAVI versus SAVR in patients with symptomatic severe aortic valve stenosis and intermediate risk of mortality, Moritz Seiffert (Hamburg/Bochum)
14:45-15:15 pm | Coffee break
5th Session: Innovation cluster
Chairs: Rabea Hinkel
15:15-15:30 pm | Clonal hematopoesis, Andreas Zeiher, Sebastian Cremer (Frankfurt)
15:30-15:45 pm | Nucleic acid therapeutics, Julia Ritterhoff (Heidelberg)
15:45-16:00 pm | Brain heart interfaces, André Fischer (Göttingen)
16:00 - 16:10 pm | Closing remarks
16:10 - 16:30 pm | Farewell coffee & departure